EP Patent

EP4385984A1 — Pyridine-n-oxides as inhibitors of nav1.8

Assigned to Gruenenthal GmbH · Expires 2024-06-19 · 2y expired

What this patent protects

The invention relates to compounds according to general formula (I)which act as inhibitors of Na<sub>V</sub>1.8 and can be used in the treatment of pain.

USPTO Abstract

The invention relates to compounds according to general formula (I)which act as inhibitors of Na<sub>V</sub>1.8 and can be used in the treatment of pain.

Drugs covered by this patent

Patent Metadata

Patent number
EP4385984A1
Jurisdiction
EP
Classification
—
Expires
2024-06-19
Drug substance claim
No
Drug product claim
No
Assignee
Gruenenthal GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.